… patients after previous failure to anti-tumour necrosis factor (… This was an observational,
retrospective multicentre study based on … recommend vedolizumab and ustekinumab for many …

… While ustekinumab demonstrates good efficacy in psoriatic … /2 studies and safety data from
the Psoriasis Longitudinal … a review of psoriasis management in the setting of commonly …

… In a retrospective, multicenter study, Navarro et al. evaluated the effect of ustekinumab
and TNF inhibitors in 20 patients with concurrent hepatitis C and five patients with hepatitis B. …

… Therefore, regular follow-up and timely adjustment were … A multicentric prospective
cohort study [28] using different … Only one patient using ustekinumab experienced virologic …

… a first-line management option in patients with acute psoriatic … six EP patients in a retrospective,
multicenter study [Citation… ustekinumab in the management of chronic plaque psoriasis […

… of ustekinumab in HIV-positive patients affected by psoriasis [… described of a patient with
chronic viral hepatitis B treated with … Moreover, several case reports and retrospective studies …

… hepatitis B or C, date of highly active antiretroviral therapy (… and biologics (anti-tumor necrosis
factor [TNF], ustekinumab, or … this is the first multicenter study addressing the impact of HIV …

… In a 52-week multicentre retrospective study, the efficacy of … study evaluated the efficacy
and safety of ustekinumab in … , it may be a valuable option in pediatric patients who refuse …

… Recently, a multicenter study was conducted evaluating the … and hepatitis B/C is advocated
and mandatory in high-risk … If failure occurs, we propose ustekinumab, tofacitinib, or …

… anti-tumor necrosis factor (TNF) agent (n/N = 24/44, 64.8%), … immunodeficiency virus (HIV)
(n/N = 2/44, 4.5%), hepatitis B (… Moreover, our multicenter study shows that the risankizumab …